Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Fsd Pharma Inc Subordinate Voting Share (HUGE.CN)
Fsd Pharma Inc Subordinate Voting Share (HUGE.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 62,446
  • Shares Outstanding, K 39,029
  • Annual Sales, $ 0 K
  • Annual Income, $ -23,607 K
  • 60-Month Beta 1.59
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.23
Trade HUGE.CN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.72
  • Most Recent Earnings -0.26 on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Drug Specialty & Generic

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.300 +22.31%
on 05/30/23
1.710 -7.02%
on 06/05/23
+0.030 (+1.92%)
since 05/08/23
3-Month
1.300 +22.31%
on 05/30/23
2.830 -43.82%
on 04/12/23
-0.400 (-20.10%)
since 03/08/23
52-Week
0.950 +67.37%
on 06/24/22
2.830 -43.82%
on 04/12/23
+0.330 (+26.19%)
since 06/08/22

Most Recent Stories

More News
FSD Pharma to Present at Sidoti Virtual Investor Conference May 10-11

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 1.1700 (-0.85%)
HUGE.CN : 1.590 (-0.63%)
FSD Pharma Achieves Milestone in Completion of Dosing of Sentinel Subjects in First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 1.1700 (-0.85%)
HUGE.CN : 1.590 (-0.63%)
FSD Pharma Announces Plan to Spin-Out Subsidiary as Distribution to Shareholders; Shareholder Meeting Scheduled for June 29, 2023

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 1.1700 (-0.85%)
HUGE.CN : 1.590 (-0.63%)
FSD Pharma Announces Filing of Year-End 2022 Results

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 1.1700 (-0.85%)
HUGE.CN : 1.590 (-0.63%)
FSD Pharma Adds Former Celsius Holdings CEO Gerry David to Board of Advisors

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 1.1700 (-0.85%)
HUGE.CN : 1.590 (-0.63%)
FSD Pharma Announces Its Australian Entity Receives Approval to Proceed With Phase 1 Clinical Trial of Lucid-201, a Candidate for the Potential Treatment of Major Depressive Disorder

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 1.1700 (-0.85%)
HUGE.CN : 1.590 (-0.63%)
FSD Pharma (Symbol: HUGE) Renews Shareholder Intelligence Services to Investigate Possible Naked Short Selling and Appeals to The Regulators and Oversight Bodies to Look Into The Short Selling Activity Of Its Stock

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 1.1700 (-0.85%)
HUGE.CN : 1.590 (-0.63%)
Original “Shark” and Iconic Entrepreneur Kevin Harrington Joins FSD Pharma Advisory Board

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 1.1700 (-0.85%)
HUGE.CN : 1.590 (-0.63%)
FSD Pharma Presenting Two Scientific Posters on Preclinical Toxicology and Efficacy Data of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2023 Forum

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 1.1700 (-0.85%)
HUGE.CN : 1.590 (-0.63%)
FSD Pharma Regains Compliance with NASDAQ Continued Listing Requirements

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“ FSD Pharma ” or the “ Company ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions...

HUGE : 1.1700 (-0.85%)
HUGE.CN : 1.590 (-0.63%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Key Turning Points

3rd Resistance Point 1.677
2nd Resistance Point 1.653
1st Resistance Point 1.627
Last Price 1.590
1st Support Level 1.577
2nd Support Level 1.553
3rd Support Level 1.527

See More

52-Week High 2.830
Fibonacci 61.8% 2.112
Fibonacci 50% 1.890
Fibonacci 38.2% 1.668
Last Price 1.590
52-Week Low 0.950

See More

Business Summary

FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar